Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,4000.00,10/23/2015,GNRL,338122384
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,4000.00,03/07/2015,GNRL,338101872
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,4000.00,06/06/2015,GNRL,338108342
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,3500.00,07/22/2015,GNRL,338117336
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,3500.00,06/30/2015,GNRL,338117026
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,3500.00,08/11/2015,GNRL,338117576
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,3500.00,06/30/2015,GNRL,338119716
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,3500.00,11/11/2015,GNRL,338134054
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,3250.00,10/03/2015,GNRL,338122062
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,2750.00,04/01/2015,GNRL,338100752
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,2750.00,07/14/2015,GNRL,338113094
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,2750.00,09/14/2015,GNRL,338120962
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,2500.00,12/04/2013,GNRL,24121398
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,2500.00,08/29/2013,GNRL,24121405
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,2500.00,06/27/2014,GNRL,152413374
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,2500.00,04/17/2014,GNRL,152413362
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,2500.00,06/26/2014,GNRL,152413380
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,2500.00,01/26/2015,GNRL,338107960
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,2375.00,01/07/2015,GNRL,338097628
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,2200.00,08/12/2013,GNRL,31978726
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,2200.00,12/11/2013,GNRL,31978747
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,2200.00,04/07/2014,GNRL,216393752
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,2200.00,11/18/2014,GNRL,216393804
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,2200.00,01/31/2014,GNRL,216393734
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,2200.00,04/07/2014,GNRL,216393756
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,2200.00,01/15/2015,GNRL,333522782
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,2200.00,10/20/2015,GNRL,333522800
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,2000.00,11/01/2013,GNRL,103208644
128935,GNRL,"Amgen Inc.",CA,100000000203,2000.00,09/26/2013,GNRL,8938739
128935,GNRL,"Amgen Inc.",CA,100000000203,2000.00,12/13/2013,GNRL,8938746
128935,GNRL,"Amgen Inc.",CA,100000000203,2000.00,09/26/2013,GNRL,8938738
128935,GNRL,"Amgen Inc.",CA,100000000203,2000.00,01/31/2014,GNRL,138079262
128935,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2000.00,05/23/2014,GNRL,202807780
128935,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2000.00,04/28/2014,GNRL,202807802
128935,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2000.00,05/14/2014,GNRL,202807786
128935,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2000.00,09/22/2014,GNRL,202807816
128935,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2000.00,04/02/2014,GNRL,202807796
128935,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2000.00,12/16/2014,GNRL,202807808
128935,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,2000.00,11/14/2014,GNRL,193645650
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,2000.00,05/07/2014,GNRL,218588630
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,2000.00,03/17/2014,GNRL,218583578
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,2000.00,04/26/2014,GNRL,218585068
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,2000.00,01/10/2014,GNRL,218583584
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,2000.00,04/11/2014,GNRL,218585560
128935,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2000.00,06/30/2015,GNRL,330658797
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,2000.00,01/09/2015,GNRL,338096190
128935,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,2000.00,01/14/2015,GNRL,336875168
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,1800.00,03/30/2015,GNRL,338110176
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,1650.00,09/15/2015,GNRL,333522792
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,1500.00,11/01/2013,GNRL,103208646
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,1500.00,08/13/2013,GNRL,31978728
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,1500.00,08/13/2013,GNRL,31978730
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,1500.00,09/16/2013,GNRL,31978734
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,1500.00,09/16/2013,GNRL,31978736
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,1500.00,12/05/2013,GNRL,31978744
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,1500.00,07/01/2014,GNRL,216393788
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,1500.00,05/20/2014,GNRL,216393776
128935,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,1500.00,07/18/2015,GNRL,263309894
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,1373.20,03/07/2015,GNRL,338101874
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,1242.90,06/23/2015,GNRL,338117022
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,1242.90,06/23/2015,GNRL,338119712
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,1056.32,05/12/2014,GNRL,218588632
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,1045.20,09/14/2015,GNRL,338120964
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,941.80,07/14/2015,GNRL,338113134
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,914.82,11/07/2014,GNRL,216393800
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,893.90,12/04/2013,GNRL,24121402
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,877.00,04/01/2015,GNRL,338100756
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,871.00,04/17/2014,GNRL,152413384
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,863.24,07/25/2015,GNRL,338117570
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,863.20,10/12/2015,GNRL,333522794
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,850.68,03/20/2014,GNRL,218583562
128935,GNRL,"Amgen Inc.",CA,100000000203,847.47,09/18/2013,GNRL,8938742
128935,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,837.29,09/19/2014,GNRL,202135140
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,827.93,03/20/2014,GNRL,218583564
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,817.40,07/15/2015,GNRL,338117334
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,775.75,01/06/2015,GNRL,333522780
128935,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,775.00,07/17/2015,GNRL,263309906
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,750.00,08/14/2014,GNRL,218598702
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,750.00,04/15/2014,GNRL,216393760
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,743.41,09/09/2015,GNRL,333522790
128935,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,735.26,06/25/2015,GNRL,330643659
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,729.70,01/07/2015,GNRL,338097632
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,698.80,12/11/2013,GNRL,31978749
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,696.80,12/15/2015,GNRL,338134052
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,696.70,11/06/2013,GNRL,103208638
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,687.50,06/26/2014,GNRL,152413376
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,685.67,06/05/2015,GNRL,338108334
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,665.13,01/13/2014,GNRL,216393730
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,658.70,10/22/2015,GNRL,338122374
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,636.20,10/03/2015,GNRL,338122064
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,630.20,04/01/2015,GNRL,338100758
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,625.00,05/12/2015,GNRL,333522786
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,624.46,03/19/2014,GNRL,216393740
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,591.19,03/19/2014,GNRL,216393746
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,578.77,01/15/2014,GNRL,218583568
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,572.38,12/11/2013,GNRL,31978750
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,561.04,10/12/2015,GNRL,333522798
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,558.27,01/08/2015,GNRL,338096182
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,554.20,04/25/2014,GNRL,218585058
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,535.36,10/22/2015,GNRL,338122376
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,511.25,01/29/2015,GNRL,338107954
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,478.80,12/01/2015,GNRL,338134050
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,427.60,08/29/2013,GNRL,24121399
128935,GNRL,"Amgen Inc.",CA,100000000203,400.00,02/12/2014,GNRL,138079274
128935,GNRL,"Amgen Inc.",CA,100000000203,400.00,03/30/2015,GNRL,297280188
128935,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,399.00,04/16/2015,GNRL,263309900
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,392.51,06/05/2015,GNRL,338108336
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,389.76,01/08/2015,GNRL,338096184
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,379.18,01/07/2015,GNRL,338097636
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,341.87,03/07/2015,GNRL,338101880
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,338.60,01/15/2014,GNRL,218583566
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,337.88,11/16/2015,GNRL,338134048
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,324.58,04/16/2014,GNRL,218585556
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,314.73,06/26/2014,GNRL,152413382
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,311.85,06/06/2015,GNRL,338108340
128935,GNRL,"Amgen Inc.",CA,100000000203,292.62,12/20/2013,GNRL,8938743
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,290.00,04/16/2014,GNRL,218585554
128935,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,284.00,07/18/2015,GNRL,263309904
128935,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,282.00,04/17/2015,GNRL,263309902
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,269.04,07/14/2015,GNRL,338113136
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,268.64,10/03/2015,GNRL,338122066
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,251.00,06/06/2015,GNRL,338108338
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,250.00,09/30/2014,GNRL,218599306
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,250.00,08/25/2014,GNRL,218593734
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,250.00,10/31/2014,GNRL,218599308
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,242.20,01/29/2015,GNRL,338107950
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,240.00,06/03/2015,GNRL,338116452
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,240.00,08/26/2015,GNRL,338118132
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,240.00,06/09/2015,GNRL,338116526
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,240.00,09/09/2015,GNRL,338118290
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,240.00,10/14/2015,GNRL,338127998
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,240.00,08/18/2015,GNRL,338117950
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,240.00,08/11/2015,GNRL,338117952
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,240.00,08/11/2015,GNRL,338118356
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,240.00,08/18/2015,GNRL,338118394
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,240.00,07/06/2015,GNRL,338117168
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,240.00,06/17/2015,GNRL,338116810
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,240.00,12/16/2015,GNRL,338134046
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,231.64,01/29/2015,GNRL,338107948
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,229.37,03/07/2015,GNRL,338101882
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,229.05,12/04/2013,GNRL,24121403
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,218.79,10/03/2015,GNRL,338122060
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,217.84,04/25/2014,GNRL,218585060
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,212.50,01/09/2015,GNRL,338096188
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,212.20,10/23/2015,GNRL,338122382
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,209.79,01/15/2014,GNRL,218583560
128935,GNRL,"Amgen Inc.",CA,100000000203,199.88,01/18/2014,GNRL,138079266
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,192.25,04/25/2014,GNRL,218585062
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,186.97,04/03/2014,GNRL,218583570
128935,GNRL,"Amgen Inc.",CA,100000000203,186.48,09/26/2013,GNRL,8938737
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,185.00,10/23/2015,GNRL,338122380
128935,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,183.64,07/18/2015,GNRL,263309910
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,181.26,06/23/2015,GNRL,338117024
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,181.26,06/23/2015,GNRL,338119714
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,173.01,04/17/2014,GNRL,152413364
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,172.89,08/12/2013,GNRL,31978727
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,168.15,01/07/2015,GNRL,338097630
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,166.49,04/26/2014,GNRL,218585064
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,162.63,07/14/2015,GNRL,338113132
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,155.63,11/06/2013,GNRL,103208636
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,155.04,12/04/2013,GNRL,24121407
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,149.00,03/19/2014,GNRL,216393750
128935,GNRL,"Amgen Inc.",CA,100000000203,144.64,12/13/2013,GNRL,8938745
128935,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,137.61,10/23/2014,GNRL,193645644
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,137.00,01/09/2015,GNRL,338096186
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,136.87,08/29/2013,GNRL,24121408
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,132.66,03/07/2015,GNRL,338101876
128935,GNRL,"Amgen Inc.",CA,100000000203,125.09,01/16/2014,GNRL,138079268
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,125.00,10/28/2014,GNRL,216393794
128935,GNRL,"Shire North American Group Inc",MA,100000061292,125.00,11/03/2015,GNRL,301143246
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,124.72,12/15/2015,GNRL,338134044
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,121.58,04/01/2015,GNRL,338100760
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,120.00,11/06/2013,GNRL,103208640
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,119.70,07/14/2015,GNRL,338113120
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,119.67,09/14/2015,GNRL,338120958
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,119.25,01/29/2015,GNRL,338107946
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,117.00,10/22/2015,GNRL,338122378
128935,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,115.00,07/18/2015,GNRL,263309896
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,113.32,12/01/2015,GNRL,338134042
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,112.96,04/17/2014,GNRL,152413360
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,112.56,01/07/2015,GNRL,338097638
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,110.72,04/01/2015,GNRL,338100754
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,108.00,06/26/2014,GNRL,152413378
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,106.92,12/01/2015,GNRL,338134040
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,100.80,03/20/2014,GNRL,218583558
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,99.00,12/04/2014,GNRL,216393806
128935,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,97.12,12/10/2014,GNRL,193645636
128935,GNRL,"W. L. Gore & Associates, Inc.",DE,100000010774,96.45,10/06/2015,GNRL,295981644
128935,GNRL,"Amgen Inc.",CA,100000000203,93.01,09/12/2013,GNRL,8938741
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,92.40,11/06/2013,GNRL,103207486
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,92.15,06/23/2015,GNRL,338117834
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,87.47,05/06/2014,GNRL,216393772
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,86.50,08/29/2013,GNRL,24121406
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,85.18,07/29/2014,GNRL,152413388
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,84.18,11/06/2015,GNRL,338124616
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,78.00,04/16/2014,GNRL,218585562
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,75.00,12/25/2013,GNRL,31978751
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,73.84,08/27/2013,GNRL,103201602
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,73.68,03/19/2014,GNRL,216393744
128935,GNRL,"Amgen Inc.",CA,100000000203,73.32,11/08/2013,GNRL,8938748
128935,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,65.23,11/18/2015,GNRL,332490597
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,63.02,09/09/2015,GNRL,333522788
128935,GNRL,"Amgen Inc.",CA,100000000203,60.21,03/05/2014,GNRL,138079272
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,53.29,09/14/2015,GNRL,338120960
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,52.50,04/26/2014,GNRL,218585066
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,52.00,01/29/2015,GNRL,338107952
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,51.00,11/07/2015,GNRL,338122386
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,50.66,03/18/2014,GNRL,216393738
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,48.95,01/15/2014,GNRL,218585552
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,48.62,10/03/2015,GNRL,338122068
128935,GNRL,"Amgen Inc.",CA,100000000203,48.21,01/31/2014,GNRL,138079260
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,47.70,10/03/2015,GNRL,338122070
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,46.65,08/06/2013,GNRL,31978724
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,45.00,04/17/2014,GNRL,216393766
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,42.50,01/07/2015,GNRL,338097634
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,39.11,03/07/2015,GNRL,338101878
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,37.66,03/20/2014,GNRL,218585550
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,36.00,01/30/2015,GNRL,338096192
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,35.81,01/13/2014,GNRL,216393726
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,35.76,05/12/2014,GNRL,218588634
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,35.00,05/29/2014,GNRL,216393780
128935,GNRL,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,35.00,10/16/2015,GNRL,337523814
128935,GNRL,"Hospira Worldwide, Inc.",IL,100000005445,34.32,11/17/2015,GNRL,258903432
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,33.44,06/27/2014,GNRL,152413372
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,33.41,07/30/2014,GNRL,152413386
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,31.52,04/01/2015,GNRL,338100918
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,30.18,07/15/2015,GNRL,338117836
128935,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,30.00,07/18/2015,GNRL,263309898
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,28.83,06/27/2014,GNRL,152413370
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,28.05,06/24/2014,GNRL,216393784
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,26.00,11/07/2015,GNRL,338122388
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,26.00,07/22/2015,GNRL,338117342
128935,GNRL,"Baxter Healthcare",IL,100000011010,25.28,10/08/2013,GNRL,104776432
128935,GNRL,"Amgen Inc.",CA,100000000203,25.00,11/08/2013,GNRL,8938747
128935,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,25.00,05/23/2014,GNRL,202807784
128935,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,25.00,04/02/2014,GNRL,202807798
128935,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,25.00,05/14/2014,GNRL,202807791
128935,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,25.00,04/28/2014,GNRL,202807806
128935,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,25.00,12/16/2014,GNRL,202807812
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,24.75,12/03/2013,GNRL,31978741
128935,GNRL,"NxStage Medical, Inc.",MA,100000005488,24.02,08/21/2013,GNRL,147359720
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,24.00,08/29/2013,GNRL,24121404
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,24.00,05/10/2014,GNRL,218585070
128935,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,24.00,11/19/2015,GNRL,319714182
128935,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,23.24,10/29/2015,GNRL,283377060
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,23.16,04/21/2014,GNRL,216393770
128935,GNRL,"Mallinckrodt LLC",MO,100000005429,23.11,08/27/2015,GNRL,334456404
128935,GNRL,"Questcor Pharmaceuticals",CA,100000010569,22.96,10/16/2013,GNRL,30076679
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,22.71,12/10/2015,GNRL,333522804
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,22.35,08/06/2014,GNRL,218593208
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,22.31,09/23/2014,GNRL,216393792
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,22.28,08/04/2014,GNRL,216393790
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,22.25,12/03/2013,GNRL,31978742
128935,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,22.16,11/19/2015,GNRL,318552300
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,21.54,12/15/2015,GNRL,338125388
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,20.97,08/29/2013,GNRL,24121400
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,20.86,03/03/2014,GNRL,218578572
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,20.82,12/03/2013,GNRL,31978740
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,20.68,10/21/2015,GNRL,338121746
128935,GNRL,"Questcor Pharmaceuticals",CA,100000010569,20.52,08/01/2013,GNRL,30076677
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,20.23,04/06/2015,GNRL,333522784
128935,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,20.05,09/02/2015,GNRL,263309908
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,20.00,10/03/2015,GNRL,338122072
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,19.95,11/06/2013,GNRL,103207488
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,19.95,07/14/2015,GNRL,338113130
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,19.91,04/01/2015,GNRL,338100916
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,19.75,12/10/2014,GNRL,218603950
128935,GNRL,"NxStage Medical, Inc.",MA,100000005488,19.33,04/07/2015,GNRL,298441492
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,19.00,12/04/2013,GNRL,24121401
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,18.85,12/03/2013,GNRL,31978743
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,18.76,01/29/2015,GNRL,338096768
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,18.73,09/23/2013,GNRL,103201928
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,18.71,05/21/2014,GNRL,218587574
128935,GNRL,"Shire North American Group Inc",MA,100000061292,18.13,05/22/2015,GNRL,300361690
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,18.00,01/30/2015,GNRL,338096194
128935,GNRL,"Genzyme Corporation",MA,100000000297,17.00,11/11/2013,GNRL,14249755
128935,GNRL,"Astellas Pharma US Inc",IL,100000000137,16.41,08/27/2013,GNRL,101681842
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,16.03,03/06/2014,GNRL,152413368
128935,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,15.86,10/03/2013,GNRL,14023927
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,15.31,07/22/2015,GNRL,338117340
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,15.22,08/12/2013,GNRL,31978725
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,15.15,10/12/2015,GNRL,333522796
128935,GNRL,"Astellas Pharma US Inc",IL,100000000137,15.11,11/14/2013,GNRL,101674050
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,15.08,11/16/2015,GNRL,338134038
128935,GNRL,"Astellas Pharma US Inc",IL,100000000137,14.85,10/01/2014,GNRL,168478428
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,14.55,04/17/2014,GNRL,216393762
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,14.12,08/11/2015,GNRL,338117572
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,13.87,11/07/2014,GNRL,216393798
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,13.84,07/09/2015,GNRL,338111412
128935,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.77,09/26/2013,GNRL,103245138
128935,GNRL,"Shire North American Group Inc",MA,100000061292,13.37,11/11/2015,GNRL,301143258
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,13.33,10/30/2015,GNRL,333522802
128935,GNRL,"Amgen Inc.",CA,100000000203,13.09,10/20/2014,GNRL,138079280
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,13.00,08/11/2015,GNRL,338117574
128935,GNRL,"GENZYME CORPORATION",MA,100000000297,12.89,04/15/2015,GNRL,318727864
128935,GNRL,"Amgen Inc.",CA,100000000203,12.38,02/16/2015,GNRL,297280186
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,12.18,04/03/2014,GNRL,218583576
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,12.06,04/28/2014,GNRL,218585558
128935,GNRL,"Amgen Inc.",CA,100000000203,12.04,09/30/2013,GNRL,8938740
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,12.04,12/01/2015,GNRL,338134036
128935,GNRL,"Amgen Inc.",CA,100000000203,12.00,04/08/2014,GNRL,138079276
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,12.00,04/03/2014,GNRL,218583574
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,12.00,02/04/2014,GNRL,218583582
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,12.00,02/26/2015,GNRL,338107956
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,11.65,11/18/2015,GNRL,338128938
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,11.00,07/02/2015,GNRL,338117020
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,11.00,07/02/2015,GNRL,338119710
128935,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,10.66,02/19/2015,GNRL,283340284
128935,GNRL,"Astellas Pharma US Inc",IL,100000000137,10.61,05/19/2014,GNRL,168420160
128935,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,10.61,12/22/2015,GNRL,283377068
128935,GNRL,"Amgen Inc.",CA,100000000203,10.21,12/10/2014,GNRL,138079282
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,10.00,04/03/2014,GNRL,218583572
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,9.99,10/20/2014,GNRL,218600174
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,9.67,05/13/2015,GNRL,338106598
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,7.58,11/22/2013,GNRL,103208642
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,5.59,07/02/2015,GNRL,338117018
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,5.59,07/02/2015,GNRL,338119708
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,3.92,02/04/2014,GNRL,218583580
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,3.39,12/05/2013,GNRL,31978745
128935,GNRL,"Amgen Inc.",CA,100000000203,3.33,01/31/2014,GNRL,138079264
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,3.30,02/26/2015,GNRL,338107958
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,2.79,08/13/2013,GNRL,31978729
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,2.58,08/13/2013,GNRL,31978731
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,2.37,09/16/2013,GNRL,31978735
128935,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,2.02,04/17/2014,GNRL,152413358
128935,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,1.79,07/14/2015,GNRL,338113138
128935,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,1.69,09/16/2013,GNRL,31978737
